The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma

Annals of Surgical Oncology

Volumn 19, Issue 13, 2012, Pages 4307-4313

  Mohebati, A ^a   Ganly, I ^a   Busam, K J ^a   Coit, D ^a   Kraus, D H ^a   Shah, J P ^a   Patel, S G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BRESLOW THICKNESS; CANCER RECURRENCE; CANCER STAGING; CLARK THICKNESS; CLINICAL ARTICLE; DESMOPLASTIC MELANOMA; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; LYMPH VESSEL METASTASIS; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

AGED; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MELANOMA; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84876503742     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2468-2     Document Type: Review

References (43)

1. Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer. 1971;28:914-36.
2. Reed RJ, Leonard DD. Neurotropic melanoma. A variant of desmoplastic melanoma. Am J Surg Pathol. 1979;3:301-11. (Pubitemid 9228785)
3. Egbert B, Kempson R, Sagebiel R. Desmoplastic malignant melanoma. A clinicohistopathologic study of 25 cases. Cancer. 1988;62:2033-41. (Pubitemid 18261833)
4. Jain S, Allen PW. Desmoplastic malignant melanoma and its variants. A study of 45 cases. Am J Surg Pathol. 1989;13:358-73. (Pubitemid 19134066)
5. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer. 1998;83:1128-35. (Pubitemid 28419065)
6. Livestro DP, Muzikansky A, Kaine EM, et al. Biology of des-moplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol. 2005;23:6739-46. (Pubitemid 46190269)
7. Posther KE, Selim MA, Mosca PJ, et al. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. Ann Surg Oncol. 2006;13:728-39.
8. Busam KJ, Mujumdar U, Hummer AJ, et al. Cutaneous desmo-plastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol. 2004;28:1518-25. (Pubitemid 39425520)
9. Skelton HG, Smith KJ, Laskin WB, et al. Desmoplastic malignant melanoma. J Am Acad Dermatol. 1995;32(5 Pt. 1):717-25.
10. McCarthy SW, Scolyer RA, Palmer AA. Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology. 2004;36:445-51. (Pubitemid 39273988)
11. Busam K. Desmoplastic melanoma. Surg Pathol. 2009;2:10.
12. George E, McClain SE, Slingluff CL, et al. Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis. J Cutan Pathol. 2009;36:425-32.
13. Maurichi A, Miceli R, Camerini T, et al. Pure desmoplastic melanoma: a melanoma with distinctive clinical behavior. Ann Surg. 2010;252:1052-7.
14. Payne WG, Kearney R, Wells K, et al. Desmoplastic melanoma. Am Surg. 2001;67:1004-6. (Pubitemid 33738135)
15. Pawlik TM, Ross MI, Prieto VG, et al. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer. 2006;106:900-6. (Pubitemid 43238458)
16. Carlson JA, Dickersin GR, Sober AJ, et al. Desmoplastic neu-rotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer. 1995;75:478-94.
17. Lens MB, Dawes M, Newton-Bishop JA, et al. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg. 2002;89:1223-7. (Pubitemid 36002537)
18. Nguyen CL, McClay EF, Cole DJ, et al. Melanoma thickness and histology predict sentinel lymph node status. Am J Surg. 2001; 181:8-11. (Pubitemid 32209113)
19. Wagner JD, Gordon MS, Chuang TY, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer. 2000;89:453-62. (Pubitemid 30489897)
20. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-48. (Pubitemid 32786276)
21. Gyorki DE, Busam K, Panageas K, et al. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol. 2003;10:403-7. (Pubitemid 40486938)
22. Patel SG, Coit DG, Shaha AR, et al. Sentinel lymph node biopsy for cutaneous head and neck melanomas. Arch Otolaryngol Head Neck Surg. 2002;128:285-91. (Pubitemid 34218582)
23. Murali R, Shaw HM, Lai K, et al. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Cancer. 2010; 116:4130-8.
24. Su LD, Fullen DR, Lowe L, et al. Desmoplastic and neurotropic melanoma. Cancer. 2004;100:598-604.
25. Chen JY, Hruby G, Scolyer RA, et al. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer. 2008;113:2770-8.
26. Hawkins WG, Busam KJ, Ben-Porat L, et al. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol. 2005;12:207-13. (Pubitemid 40568907)
27. de Almeida LS, Requena L, Rutten A, et al. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases. Am J Dermatopathol. 2008;30:207-15.
28. Smithers BM, McLeod GR, Little JH. Desmoplastic melanoma: patterns of recurrence. World J Surg. 1992;16:186-90.
29. Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol. 2005;152:673-8. (Pubitemid 40571298)
30. Busam KJ, Zhao H, Coit DG, et al. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling. J Invest Dermatol. 2005;124:412-8.
31. Busam KJ, Kucukgol D, Eastlake-Wade S, et al. Clusterin expression in primary and metastatic melanoma. J Cutan Pathol. 2006;33:619-23. (Pubitemid 44370059)
32. Anstey A, McKee P, Jones EW. Desmoplastic malignant melanoma: a clinicopathological study of 25 cases. Br J Dermatol. 1993;129:359-71. (Pubitemid 23308236)
33. Vongtama R, Safa A, Gallardo D, et al. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma. Head Neck. 2003;25:423-8. (Pubitemid 36577024)
34. Foote MC, Burmeister B, Burmeister E, et al. Desmoplastic melanoma: the role of radiotherapy in improving local control. ANZ J Surg. 2008;78:273-6. (Pubitemid 351432698)
35. Wharton JM, Carlson JA, Mihm MC Jr. Desmoplastic malignant melanoma: diagnosis of early clinical lesions. Hum Pathol. 1999;30:537-42. (Pubitemid 29218047)
36. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-83. (Pubitemid 29109331)
37. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006; 355:1307-17. (Pubitemid 44465459)
38. Gershenwald JE, Mansfield PF, Lee JE, et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick ([ or =4 mm) primary melanoma. Ann Surg Oncol. 2000;7:160-5. (Pubitemid 30164687)
39. Bichakjian CK, Halpern AC, Johnson TM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011;65:1032-47.
40. Thelmo MC, Sagebiel RW, Treseler PA, et al. Evaluation of sentinel lymph node status in spindle cell melanomas. J Am Acad Dermatol. 2001;44:451-5. (Pubitemid 32199964)
41. Jaroszewski DE, Pockaj BA, DiCaudo DJ, et al. The clinical behavior of desmoplastic melanoma. Am J Surg. 2001;182:590-5. (Pubitemid 34142677)
42. Petersson F, Diwan AH, IVan D, et al. Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival. J Cutan Pathol. 2009;36:1157-63.
43. Schmidt CR, Panageas KS, Coit DG, et al. An increased number of sentinel lymph nodes is associated with advanced Breslow depth and lymphovascular invasion in patients with primary melanoma. Ann Surg Oncol. 2009;16:948-52.